Sarda Proteins (BOM:519242) EV-to-EBIT : -204.05 (As of May. 01, 2024)

Sarda Proteins EV-to-EBIT Chart

Sarda Proteins Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
EV-to-EBIT		Get a 7-Day Free Trial					-11.95	10.33	26.70	17.31	758.48

Sarda Proteins Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															45.61	758.48	968.19	17,445.54	-201.01

Competitive Comparison of Sarda Proteins's EV-to-EBIT

For the Packaged Foods subindustry, Sarda Proteins's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sarda Proteins's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Sarda Proteins's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sarda Proteins's EV-to-EBIT falls into.

Sarda Proteins EV-to-EBIT Calculation

Sarda Proteins's EV-to-EBIT for today is calculated as:

Sarda Proteins's current Enterprise Value is ₹74.48 Mil.
Sarda Proteins's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sarda Proteins  (BOM:519242) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Sarda Proteins's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Sarda Proteins's Enterprise Value for the quarter that ended in Dec. 2023 was ₹73.37 Mil.
Sarda Proteins's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sarda Proteins EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Sarda Proteins's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Sarda Proteins (BOM:519242) Business Description